Status:
TERMINATED
ECT/Succinylcholine: Biochemical, Serum and Cardiovascular Changes
Lead Sponsor:
University of California, San Francisco
Conditions:
Depression
Eligibility:
All Genders
18+ years
Brief Summary
This study will be conducted to determine the pharmacodynamics, cardiovascular and biochemical effects of succinylcholine when given during electroconvulsive therapy. (ECT). This is a single center, p...
Detailed Description
Patients will receive the anesthetic that is traditionally given which includes appropriate doses of succinylcholine. Serum potassium and creatinine phosphokinase (CK) levels will be determined pre an...
Eligibility Criteria
Inclusion
- A male or non-pregnant female aged 18 years and older
- American Society of Anesthesiologists physical status 1, 2, 3
- Scheduled to undergo electroconvulsive therapy under general anesthesia
- Have given written informed consent
Exclusion
- Pregnant or nursing
- Any patient in the study investigators opinion who may not be suitable for research.
Key Trial Info
Start Date :
October 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 30 2015
Estimated Enrollment :
13 Patients enrolled
Trial Details
Trial ID
NCT00750906
Start Date
October 1 2008
End Date
April 30 2015
Last Update
January 18 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California San Francisco
San Francisco, California, United States, 94143